National Institute for Health and Clinical Excellence (NICE)
NICE 20th Anniversary: Parliamentary Reception and Awards
NICE has hosted a parliamentary reception and awards ceremony in celebration of its 20th anniversary.
The event, held on Wednesday, June 12, in the Terrace Pavilion of the House of Commons at the Palace of Westminster, was a celebration of NICE’s success over the past 20 years and a look ahead to the future.
Around 200 invited guests came from a broad range of national and local organisations along with individuals and parliamentarians who work alongside NICE and take a real interest in the work the institute does, including Royal Colleges, patient groups, industry bodies and academic institutions.
During the evening the Distinguished Contribution to NICE Awards were presented by NICE’s chair Sir David Haslam to 20 individuals who have made an outstanding contribution to the organisation since it was established in 1999.
List of award winners:
Professor Sir Michael Rawlins - Founding chair of NICE, from 1999 to 2013. He led the organisation in its formative years and through the evolution of its main programmes.
Mercy Jeyasingham MBE – A non-executive director of the NICE board from 2001 to 2013. Mercy made an important contribution to the early development and governance of NICE.
Professor Anthony Culyer CBE – Played an influential role in the development of NICE, through his work as a non-executive director.
Professor Catherine Law CBE – Inaugural chair of NICE's public health interventions advisory committee from 2005 to 2015. Helped to establish the credibility of NICE’s public health programme among public health professionals.
Professor David Barnett – Inaugural chair of the first appraisal committee for ten years, making a formative contribution to the development of NICE’s methods and processes.
Jean Gaffin OBE – An inaugural member of NICE’s appraisal committee. Her advocacy for patients and those who speak for them had a formative influence on NICE’s appraisal methods.
Professor Bruce Campbell – Chaired both the interventional procedures and the medical technologies advisory committees between 2002 and 2015 and was instrumental in developing their methods and processes.
Dr Tessa Lewis – Chaired several NICE advisory committees, including, since 2016, the managing common infections advisory committee, the quality standards advisory committee from 2012 and the indicators advisory committee since 2015.
Professor Andrew Stevens – The longest-serving committee member and chair before stepping down in 2017, Andrew played a formative role in the development of the technology appraisal programme.
Dr Jane Adam – Chair and member of NICE’s appraisal committees since 2009.
Andrew McKeon – Andy spent eight years as a non-executive director and then deputy chair of the NICE Board.
Professor Rona McCandlish – Former non-executive director of NICE from 2007 to 2016, Rona made a significant contribution to the development of the guidelines programme.
Patrick Storrie – Since the introduction of NICE’s external appeal panel, Paddy has served the panel with distinction, chairing eight appeals and acting as a lay member for another two.
Dr Amanda Adler – A member of one of NICE’s appraisal committees since 2006 and chair since 2009, Amanda has contributed to the development of NICE’s technology appraisal methods and processes.
Professor Stephen Pilling – As co-director of the former Mental Health Guidelines Collaborating Centre and chair of several NICE clinical guideline committees, Steve Pilling has made a significant contribution to NICE's guidelines methods and its mental health guidance.
Bridget Warr CBE – As chair of two NICE social care guideline development groups and member of a quality standard group, Bridget Warr has helped to shape the development of NICE's guidelines for the social care sector.
Dr Margaret Helliwell – A former non-executive director of NICE and subsequently vice chair of the board, between 2007 and 2015, Maggie made a significant contribution to the governance of the institute.
Julia Earnshaw – Led GlaxoSmithKline’s engagement with NICE. Julia influenced the development of NICE’s methods and helped to create a positive relationship between the life sciences industry and NICE.
Professor Martin Eccles – Founding chair of the guidelines advisory committee and instrumental in designing NICE’s approach to guideline development. He was also chair of the implementation strategy group and has been a mentor for our fellows and scholars programme.
Professor Sir David Haslam – Founding chair of NICE's accreditation advisory committee and has been chair of the NICE Board since 2013, leading the organisation with distinction through a period of significant external change.
NICE would like to thank all who attended and thank those who received awards for their fantastic contribution to the institute over the past 20 years.
Latest News from
National Institute for Health and Clinical Excellence (NICE)
Commonly used treatments for chronic pain can do more harm than good and should not be used, says NICE in draft guidance04/08/2020 11:15:00
A number of commonly used drug treatments for chronic primary pain have little or no evidence that they work and shouldn’t be prescribed, NICE said in its draft clinical guideline published yesterday (3 August 2020) on the assessment and management of chronic pain in over 16s.
New combination treatment for patients with advanced kidney cancer31/07/2020 13:10:00
Adults with advanced renal cell carcinoma can now be offered avelumab with axitinib as a first line treatment option on the Cancer Drugs Fund (CDF), NICE has said in final draft guidance.
NICE publishes new COVID-19 rapid guideline on arranging planned care in hospitals and diagnostic services28/07/2020 09:15:00
NICE yesterday (27 July 2020) published a guideline on the arrangements the NHS should put in place for patients needing elective surgery and other planned treatments and procedures (including diagnostics and imaging) during the COVID-19 pandemic.
NICE signs agreement with Colombia’s Institute of Health Technology Assessment to forge closer working ties10/07/2020 14:05:00
Research and knowledge sharing key to collaborative working approach agreed the two agencies
NICE’s strategy on sustainability: current progress and next steps10/07/2020 09:15:00
Fizzah Ali, NICE clinical fellow, outlines the key steps towards a sustainability strategy at NICE.
Innovation through HTA: theme for HTAi 2021 Annual Meeting announced06/07/2020 13:43:00
Health Technology Assessment International (HTAi) has announced the theme for the 2021 Annual Meeting which will be held from 19-23 June in Manchester.
Cancer patients to benefit from new histology independent treatment26/06/2020 16:15:00
Entrectinib (Rozlytrek, Roche), a revolutionary treatment for a range of cancers, is the second histology independent drug to be recommended by NICE for use on the Cancer Drugs Fund (CDF).
Steam treatment recommended for men with an enlarged prostate25/06/2020 16:15:00
Minimally invasive procedure involves injecting steam to destroy excess prostate tissue.
NICE draft guidance does not recommend siponimod for treating secondary progressive multiple sclerosis25/06/2020 13:43:00
NICE has today (25 June 2020) issued draft guidance for public consultation which does not recommend siponimod (also called Mayzent and made by Novartis) for treating secondary progressive multiple sclerosis (MS).